Addex to Present at the 28th Medtech Investing Europe Conference

Addex to Present During the Swiss Biotech Day

ADDEX REPORTS 2018 FULL YEAR AUDITED RESULTS AND PROVIDES CORPORATE UPDATE

Addex to Announce 2018 Full Year Audited Results on April 30, 2019

Addex to Participate in the BIOEurope Spring Conference

Addex to Present at the Cowen 39th Annual Health Care Conference on March 13, 2019

Addex Trading Update in Accordance with Art. 53 of the SIX Listing Rules (Ad hoc publicity)

Addex and Indivior to Accelerate Additional GABAB PAM Compounds for Addiction as Indivior Elects to Stop Development of ADX71441

Addex Trading Update: Completes 2018 with Strong Cash Position

Addex Van Leeuwenhoeck Equity Research Report Highlights Deep Pipeline Well Funded through Pivotal Registration Study and Increases Price Target to CHF 14